BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24606940)

  • 21. Structure of the UspA1 protein fragment from Moraxella catarrhalis responsible for C3d binding.
    Mikula KM; Kolodziejczyk R; Goldman A
    J Struct Biol; 2019 Nov; 208(2):77-85. PubMed ID: 31400508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation.
    Atkins KL; Burman JD; Chamberlain ES; Cooper JE; Poutrel B; Bagby S; Jenkins AT; Feil EJ; van den Elsen JM
    Mol Immunol; 2008 Mar; 45(6):1600-11. PubMed ID: 18061675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Energetic evaluation of binding modes in the C3d and Factor H (CCP 19-20) complex.
    E S Harrison R; Gorham RD; Morikis D
    Protein Sci; 2015 May; 24(5):789-802. PubMed ID: 25628052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus.
    Hammel M; Sfyroera G; Pyrpassopoulos S; Ricklin D; Ramyar KX; Pop M; Jin Z; Lambris JD; Geisbrecht BV
    J Biol Chem; 2007 Oct; 282(41):30051-61. PubMed ID: 17699522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d.
    Bhattacharjee A; Lehtinen MJ; Kajander T; Goldman A; Jokiranta TS
    Mol Immunol; 2010 May; 47(9):1686-91. PubMed ID: 20378178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Sbi protein is a multifunctional immune evasion factor of Staphylococcus aureus.
    Smith EJ; Visai L; Kerrigan SW; Speziale P; Foster TJ
    Infect Immun; 2011 Sep; 79(9):3801-9. PubMed ID: 21708997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion.
    Amdahl H; Jongerius I; Meri T; Pasanen T; Hyvärinen S; Haapasalo K; van Strijp JA; Rooijakkers SH; Jokiranta TS
    J Immunol; 2013 Aug; 191(4):1775-84. PubMed ID: 23863906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21).
    Clemenza L; Isenman DE
    J Immunol; 2000 Oct; 165(7):3839-48. PubMed ID: 11034390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights Into the Structure-Function Relationships of Dimeric C3d Fragments.
    Wahid AA; Dunphy RW; Macpherson A; Gibson BG; Kulik L; Whale K; Back C; Hallam TM; Alkhawaja B; Martin RL; Meschede I; Laabei M; Lawson ADG; Holers VM; Watts AG; Crennell SJ; Harris CL; Marchbank KJ; van den Elsen JMH
    Front Immunol; 2021; 12():714055. PubMed ID: 34434196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solution structure of TT30, a novel complement therapeutic agent, provides insight into its joint binding to complement C3b and C3d.
    Li K; Gor J; Holers VM; Storek MJ; Perkins SJ
    J Mol Biol; 2012 May; 418(3-4):248-63. PubMed ID: 22387467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A crystal structure of the complex between human complement receptor 2 and its ligand C3d.
    van den Elsen JM; Isenman DE
    Science; 2011 Apr; 332(6029):608-11. PubMed ID: 21527715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure of complement receptor (CR) 2 and CR2-C3d complexes.
    Hannan J; Young K; Szakonyi G; Overduin MJ; Perkins SJ; Chen X; Holers VM
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):983-9. PubMed ID: 12440958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d.
    Hannan JP; Young KA; Guthridge JM; Asokan R; Szakonyi G; Chen XS; Holers VM
    J Mol Biol; 2005 Feb; 346(3):845-58. PubMed ID: 15713467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel method for detecting complement C3 deposition on Staphylococcus aureus.
    Wonfor T; Li S; Dunphy RW; Macpherson A; van den Elsen J; Laabei M
    Sci Rep; 2022 Sep; 12(1):15766. PubMed ID: 36130996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b.
    Koch TK; Reuter M; Barthel D; Böhm S; van den Elsen J; Kraiczy P; Zipfel PF; Skerka C
    PLoS One; 2012; 7(10):e47638. PubMed ID: 23071827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solvation effects in calculated electrostatic association free energies for the C3d-CR2 complex and comparison with experimental data.
    Cheung AS; Kieslich CA; Yang J; Morikis D
    Biopolymers; 2010 Jun; 93(6):509-19. PubMed ID: 20091675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Staphylococcus aureus small RNA is required for bacterial virulence and regulates the expression of an immune-evasion molecule.
    Chabelskaya S; Gaillot O; Felden B
    PLoS Pathog; 2010 Jun; 6(6):e1000927. PubMed ID: 20532214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of complement receptor 2 in complex with its C3d ligand.
    Szakonyi G; Guthridge JM; Li D; Young K; Holers VM; Chen XS
    Science; 2001 Jun; 292(5522):1725-8. PubMed ID: 11387479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H.
    Hellwage J; Jokiranta TS; Friese MA; Wolk TU; Kampen E; Zipfel PF; Meri S
    J Immunol; 2002 Dec; 169(12):6935-44. PubMed ID: 12471127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The solvent at antigen-binding site regulated C3d-CR2 interactions through the C-terminal tail of C3d at different ion strengths: insights from molecular dynamics simulation.
    Zhang Y; Guo J; Li L; Liu X; Yao X; Liu H
    Biochim Biophys Acta; 2016 Oct; 1860(10):2220-31. PubMed ID: 27154286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.